In the international business, the US Generics division grew by 5%, contributing ₹467 crore, with eight new product launches in the US market.

Plus: How AI can help cancer patients avoid unnecessary chemotherapies and make it easier to understand your dental X-rays.

This year’s scholar is Lucy Chadwick, who is undertaking the Executive MBA. Currently Global Partnerships Manager at Forte Healthcare, an Irish-owned animal health SME, she initially qualified and ...

Bristol Myers Squibb (NYSE: BMY) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.

Lifco has signed an agreement to acquire a majority of the shares in the German company Kögel Filter GmbH - Contecma ...

Streamlining processes like trial site selection and FDA documentation can make a meaningful difference in development timelines.

Ali Ghamrawy, Chairperson of the Egyptian Drug Authority (EDA) has reported that the total sales of Egypt's <a target=_blank ...

Highlights:,Baird upgraded McKesson Corporation’s stock from Neutral to Outperform, raising its price target to $688 from $531.,McKesson's strong performance in the U.S. Pharmaceutical Distribution ...

ProKidney's REACT® therapy shows kidney function stabilization. Find out why PROK stock is risky due to cash issues and ...

Pacylex Pharmaceuticals Contact: Michael J. WeickertCEO, Pacylex Pharmaceuticals, Inc.E: michael.weickert@pacylex.com P: 650-218-1840Twitter @Pacylex https://twitter.com/pacylex LinkedIn ...